位置:成果数据库 > 期刊 > 期刊详情页
Morroniside antagonizes tau hyperphosphorylation against neurodegeneration:a cell culture study
  • ISSN号:1000-3002
  • 期刊名称:《中国药理学与毒理学杂志》
  • 时间:0
  • 分类:R96[医药卫生—药理学;医药卫生—药学]
  • 作者机构:Department of Pharmacology,Xuanwu Hospital of Capital Medical University,Beijing Institute for Brain disorder,Key Laboratory for Neurodegenerative Diseases of Ministry of Education
  • 相关基金:The project supported by National Natural Science Foundation of China(81274120,81473373);Beijing Natural Science Foundation(7132110);Beijing Health and Technical High-level Personal Plan(2014-2-014);the Capital Health Research and Development Foundation(2011-1001-05)
中文摘要:

OBJECTIVE Protein phosphatase 2A(PP2A),a major protein phosphatase,have been reported to be involved in the microtubule-associated protein tau hyperphosphorylation and aggregation in Alzheime disease(AD).Morroniside(MOR)is the isolated component from Cornus officinalis Sieb.et Zucc.The present study is to investigate the inhibitory effect of MOR on tau hyperphosphorylation and the underlying mechanisms.METHODS SK-N-SH cells were pretreated with MOR 50-200μmol·L-1 for 24 hand then treated with okadaic acid(OA)(20nmol·L-1)for 6h to induce tau hyperphosphorylation by inhibiting PP2A activity.To determine whether the inhibitory effect of MOR on tau hyperphosphorylation was dependent on PP2A directly,we transfected PP2Ac siRNA into HEK293 cells.Cell morphology was visualized under contrast microscope.Western blotting was used to measure the expressions of phosphorylated tau,total tau,Protein phosphatase-2A(PP2A),phosphorylated PP2 Aat Tyr307(P-PP2A),demethylated PP2 Aat Leu309(DM-PP2A),protein phosphatase methylesterase 1(PME-1),Leucine carboxyl methyltransferase 1(LCMT-1),phosphorylated Src at Tyr416 and Tyr529,total Src,glycogen synthase kinase-3β(GSK-3β)and phospho-GSK3β(Ser9).The activity of PP2 A was measured by aprotein phosphatases activity assay kit.RESULTS Compared with the control,the OA-treated cells became retracted and rounded up and their tau phosphorylation levels at pSer199/202,pT205,pT212,pS214,pT217 markedly increased.Pretreatment with MOR improved the cellular morphology and reduced OA-induced tau hyperphosphorylation.In addition,MOR treatment increased PP2 Aactivity accompanied by a decrease of DM-PP2 Aand P-PP2 Aexpression.MOR decreased PME-1expression and the ratio of PME/LCMT-1.Furthermore,MOR treatment altered the level of Src phosphorylated at Tyr416,which can regulate phosphorylation of PP2 A.PP2Ac siRNA could inhibit PP2Ac expression and induce tau hyperphosphorylation.MOR had no effect on PP2Ac expression,correspondingly,didn′t affect tau hyperphosphorylation in PP2Ac siRNA transfec

英文摘要:

OBJECTIVE Protein phosphatase 2A(PP2A),a major protein phosphatase,have been reported to be involved in the microtubule-associated protein tau hyperphosphorylation and aggregation in Alzheime disease(AD).Morroniside(MOR)is the isolated component from Cornus officinalis Sieb.et Zucc.The present study is to investigate the inhibitory effect of MOR on tau hyperphosphorylation and the underlying mechanisms.METHODS SK-N-SH cells were pretreated with MOR 50-200μmol·L-1 for 24 hand then treated with okadaic acid(OA)(20nmol·L-1)for 6h to induce tau hyperphosphorylation by inhibiting PP2A activity.To determine whether the inhibitory effect of MOR on tau hyperphosphorylation was dependent on PP2A directly,we transfected PP2Ac siRNA into HEK293 cells.Cell morphology was visualized under contrast microscope.Western blotting was used to measure the expressions of phosphorylated tau,total tau,Protein phosphatase-2A(PP2A),phosphorylated PP2 Aat Tyr307(P-PP2A),demethylated PP2 Aat Leu309(DM-PP2A),protein phosphatase methylesterase 1(PME-1),Leucine carboxyl methyltransferase 1(LCMT-1),phosphorylated Src at Tyr416 and Tyr529,total Src,glycogen synthase kinase-3β(GSK-3β)and phospho-GSK3β(Ser9).The activity of PP2 A was measured by aprotein phosphatases activity assay kit.RESULTS Compared with the control,the OA-treated cells became retracted and rounded up and their tau phosphorylation levels at pSer199/202,pT205,pT212,pS214,pT217 markedly increased.Pretreatment with MOR improved the cellular morphology and reduced OA-induced tau hyperphosphorylation.In addition,MOR treatment increased PP2 Aactivity accompanied by a decrease of DM-PP2 Aand P-PP2 Aexpression.MOR decreased PME-1expression and the ratio of PME/LCMT-1.Furthermore,MOR treatment altered the level of Src phosphorylated at Tyr416,which can regulate phosphorylation of PP2 A.PP2Ac siRNA could inhibit PP2Ac expression and induce tau hyperphosphorylation.MOR had no effect on PP2Ac expression,correspondingly,didn′t affect tau hyperphosphorylation in PP2Ac siRNA transfec

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国药理学与毒理学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:军事医学科学院
  • 主办单位:军事医学科学院毒物药物研究所 中国药理学会 中国毒理学会
  • 主编:张永祥
  • 地址:北京市海淀区太平路27号
  • 邮编:100850
  • 邮箱:cjpt518@163.com
  • 电话:010-68276743
  • 国际标准刊号:ISSN:1000-3002
  • 国内统一刊号:ISSN:11-1155/R
  • 邮发代号:82-140
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:9749